Scholars@Duke
Julie Ann Raffi

Julie Ann Raffi

Assistant Professor of Radiation Oncology
Radiation Oncology
julie.raffi@duke.edu
40 Duke Medicine Circle, Box 3295, Durham, NC 27710
40 Duke Medicine Circle, Box 3295, Durham, NC 27710

Selected Publications

Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism.

Journal Article J Appl Clin Med Phys · January 2025 PURPOSE: This retrospective analysis was completed to investigate the use of a model-based dose calculation algorithm (MBDCA) AcurosBV, for use in HDR BT treatments for locally advanced cervical cancer treated with tandem and ovoid applicators with interst ... Full text Link to item Cite

A novel multi-modality imaging phantom for validating interstitial needle guidance for high dose rate gynecological brachytherapy.

Journal Article J Appl Clin Med Phys · October 2023 PURPOSE: To design, manufacture, and validate a female pelvic phantom for multi-modality imaging (CT, MRI, US) to benchmark a commercial needle tracking system with application in HDR gynecological (GYN) interstitial procedures. MATERIALS AND METHODS: A GY ... Full text Open Access Link to item Cite

What is appropriate target delineation for MRI-based brachytherapy for medically inoperable endometrial cancer?

Journal Article Brachytherapy · 2023 PURPOSE: For medically inoperable endometrial cancer (MIEC), the volumetric target of image-guided brachytherapy (IGBT) techniques is not well established. We propose a high-risk CTV (HRCTV) concept and report associated rates of local control and toxicity ... Full text Link to item Cite

TU‐D‐BRB‐08: Comparison of TLD Measured Dose, TG‐43 Dose, and Grid‐Based Boltzmann Solver Dose from Intracavitary APBI for Multiple Reference Locations in a Phantom

Conference Medical Physics · January 1, 2010 Purpose: To quantify the difference between inhomogeneity‐corrected brachytherapy treatment planning dose calculations and regular homogeneous (TG‐43) dose calculations and to compare the results from both calculation methods with TLD measurements for well ... Full text Cite

Determination of exit skin dose for i 192 r intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters

Journal Article Medical Physics · January 1, 2010 Purpose: Intracavitary accelerated partial breast irradiation (APBI) has become a popular treatment for early stage breast cancer in recent years due to its shortened course of treatment and simplified treatment planning compared to traditional external be ... Full text Cite

SU‐FF‐T‐273: Energy Dependence of TLD‐100 Chips and Microcubes for the Xoft Axxent® 50 KV Miniature X‐Ray Source and Cs‐137 Relative to Co‐60

Conference Medical Physics · January 1, 2009 Purpose: To use experimental methods to measure the overall energy dependence of LiF:Mg,Ti thermoluminescent dosimeters (TLDs) for the Xoft Axxent® miniature x‐ray source (mean energy ∼27 keV) and 137Cs (662 keV) relative to 60Co (125 ... Full text Cite

TH‐E‐AUD‐04: Determination of Exit Skin Dose for MammoSite(R) RTS with TLD

Journal Article Medical Physics · January 1, 2007 Purpose: To accurately determine the exit skin dose from MammoSite® Radiation Therapy System treatments using thermoluminescent dosimeters (TLDs) placed on the surface of the skin during each treatment fraction. Methods and Materials: Well‐characterized TL ... Full text Cite